UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Pursuant to §240.14a-12 |
PRELUDE THERAPEUTICS INCORPORATED
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ |
No fee required. |
☐ |
Fee paid previously with preliminary materials. |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
]$DVV[!%JVY=HK,35Y&U)+%
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M **** "BBB@ HHHH **** "BBB@#F+GPUAHK(-;0^H/SM]3V_#\ZY0R2+D$]ZTW
M4(.>*S[@9.1TKD^MY_[=?_LZ0?"?'_,:_P#)7_[.O2:*.9A9'G(^%0V;?[9_\E?_ +.H/^%1
M'=N_MW_R4_\ LZ]-HHYF%D>9'X19_P"8YSZ_9/\ [.FGX09.?[<_\E/_ +.O
M3Z*.9A9'F0^$6T@C7.G_ $Z?_9U+_P *IX _MK_R5_\ LZ](HHYF%D",>2LK $(3G.>1VQD]:HW7@7[3#?
M1_VCM^U:9%I^?(SMV?Q_>YSZ?K447P[M8-;-\LEG)$\RS2)/8J\NX 9V2;OE
M!(ST..<&J_=$IU;:_P!?TRR_CRS:WFDMM/OW/DR2VK,BJET$X8H=W0=><<